Findings from Oriflame’s long-term R&D programme show Oripeptide-3 supporting five key biological drivers of ageing, reinforcing its central role in NovAge+ skin longevity formulations. New scientific data from Oriflame has brought renewed attention to the biological science of skin longevity as the company revealed new findings on Oripeptide-3, its patented bioactivating technology. The research, released … Continue reading Skin biology advances as Oriflame presents new findings on Oripeptide-3 and ageing pathways